Literature DB >> 27760017

Phenotypical and Genotypical Antimicrobial Resistance of Coagulase-negative staphylococci Isolated from Cow Mastitis.

I Klimiene, M Virgailis, A Pavilonis, R Siugzdiniene, R Mockeliunas, M Ruzauskas.   

Abstract

The objectives of this study were to determine the prevalence and antimicrobial resistance of coagulase-negative staphylococci (CNS) isolated from dairy cows with subclinical mastitis. Antimicrobial resistance in staphylococci were evaluated by breakpoint values specific to the species (EU-CAST). The presence of resistance-encoding genes was detected by multiplex PCR. A total of 191 CNS isolates were obtained. The CNS isolates were typically resistant to penicillin (67.4%), tetracyc-line (18.9%), and erythromycin (13.7%). CNS isolates (78.0%) were resistant to at least one antimicrobial compound, and 22.0% were multiresistant. The multiresistant isolates were predominantly Staphylococcus chromogenes (28.6%), Staphylococcus warneri (19%) and Staphylococcus haemolyticus (14.3%). According to MIC pattern data, multiresistant isolates showed the highest resistance (p<0.05) rates to penicillin (85.7%), tetracycline (66.7%), and erythromycin (48.2%), but all of them were sensitive to daptomycin, oxacillin, qiunupristin/dalfopristin, and vancomycin. S. chromogenes (9.5%), S. haemolyticus (4.8%), and S. capitis ss capitis (2.4%) strains were resistant to methicillin; their resistance to oxacillin and penicillin was more than 8 mg/l. A high rate of resistance to penicillin was linked to a blaZ gene found in 66.6% of the isolated multiresistant CNS strains. Resistance to tetracycline via the tetK (38.1%) gene and penicillin via the mecA (23.8%) gene were detected less frequently. Gene msrAB was responsible for macrolides and lincosamides resistance and detected in 28.6% of the CNS isolates. Antimicrobial resistance genes were identified more frequently in S. epidermidis, S. chromogenes, and S. warneri.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27760017     DOI: 10.1515/pjvs-2016-0080

Source DB:  PubMed          Journal:  Pol J Vet Sci        ISSN: 1505-1773            Impact factor:   0.821


  6 in total

1.  Diversity and emergence of multi-resistant Staphylococcus spp. isolated from subclinical mastitis in cows in of the state of Piauí, Brazil.

Authors:  Raylson Pereira de Oliveira; José Givanildo da Silva; Breno Bezerra Aragão; Rafaella Grenfell de Carvalho; Maria Aparecida Juliano; Jeverson Frazzon; Márcia Paula Oliveira Farias; Rinaldo Aparecido Mota
Journal:  Braz J Microbiol       Date:  2022-09-08       Impact factor: 2.214

2.  Chitosan and cloxacillin combination improve antibiotic efficacy against different lifestyle of coagulase-negative Staphylococcus isolates from chronic bovine mastitis.

Authors:  María L Breser; Verónica Felipe; Luciana P Bohl; María S Orellano; Paula Isaac; Agustín Conesa; Virginia E Rivero; Silvia G Correa; Ismael D Bianco; Carina Porporatto
Journal:  Sci Rep       Date:  2018-03-23       Impact factor: 4.379

3.  Novel β-Lactamase blaARL in Staphylococcus arlettae.

Authors:  Sabrina N Andreis; Vincent Perreten; Sybille Schwendener
Journal:  mSphere       Date:  2017-05-03       Impact factor: 4.389

4.  Tetracycline resistance phenotypes and genotypes of coagulase-negative staphylococcal isolates from bubaline mastitis in Egypt.

Authors:  K A Abd El-Razik; A A Arafa; R H Hedia; E S Ibrahim
Journal:  Vet World       Date:  2017-06-25

5.  Prevalence and Genetic Basis of Antimicrobial Resistance in Non-aureus Staphylococci Isolated from Canadian Dairy Herds.

Authors:  Diego B Nobrega; Sohail Naushad; S Ali Naqvi; Larissa A Z Condas; Vineet Saini; John P Kastelic; Christopher Luby; Jeroen De Buck; Herman W Barkema
Journal:  Front Microbiol       Date:  2018-02-16       Impact factor: 5.640

6.  In vitro activity and In vivo efficacy of Isoliquiritigenin against Staphylococcus xylosus ATCC 700404 by IGPD target.

Authors:  Qianwei Qu; Jinpeng Wang; Wenqiang Cui; Yonghui Zhou; Xiaoxu Xing; Ruixiang Che; Xin Liu; Xueying Chen; God'spower Bello-Onaghise; Chunliu Dong; Zhengze Li; Xiubo Li; Yanhua Li
Journal:  PLoS One       Date:  2019-12-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.